Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial. [electronic resource]
Producer: 20110906Description: 339-48 p. digitalISSN:- 2040-2058
- Adenine -- adverse effects
- Adult
- Anti-HIV Agents -- adverse effects
- Atazanavir Sulfate
- Cardiovascular Diseases -- chemically induced
- Deoxycytidine -- adverse effects
- Emtricitabine
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Male
- Middle Aged
- Nevirapine -- adverse effects
- Oligopeptides -- adverse effects
- Organophosphonates -- adverse effects
- Pyridines -- adverse effects
- Reverse Transcriptase Inhibitors -- adverse effects
- Ritonavir -- adverse effects
- Tenofovir
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.